Therapeutic potential of translocatorprotein ligands for age-related macular degeneration  

作　　者：Xing Li Zhiming He Xinhua Shu 

机构地区：[1]School of Basic Medical Sciences,Shaoyang University,Shaoyang,Hunan Province,China [2]Department of Biological and Biomedical Sciences,Department of Vision Science,Glasgow Caledonian University,Glasgow,UK

出　　处：《Neural Regeneration Research》2022年第4期793-794,共2页中国神经再生研究（英文版）

基　　金：supported by the Rosetrees Trust,National Eye Research Centre,Tenovus Scotland;the Lotus Scholarship Program of Hunan Province(2019)(to XS)。

摘　　要：Age-related macular degeneration:Agerelated macular degeneration(AMD)is a retinal degenerative disorder,characterized by the irreversible loss of the central vision during ageing.This chronic,progressive disease has been estimated to currently affect around 196 million people worldwide and will increase to 288 million in 2040(Wong,et al.,2014).Early AMD is defined by the presence of drusen underneath the retinal pigment epithelial(RPE)layer.Late AMD can be divided into two groups,"wet AMD"and"dry AMD",depending on the underlying clinical features.

关 键 词：DEGENERATION AMD IRREVERSIBLE 

分 类 号：R774.5[医药卫生—眼科]